Literature DB >> 22811365

The effect of age on the paraoxonase and arylesterase activity of pregnant mothers and their infants.

Mahmut Abuhandan1, Alpay Cakmak, Abdullah Taskın, Emrah Karakaya, Abdurrahim Kocyigit, Hatip Kılıc.   

Abstract

AIM: The study aimed to research the effect of maternal age at pregnancy on the paraoxonase (PON) and arylesterase activity levels of mothers and infants.
METHOD: The study comprised 30 mothers aged more than 35 years and their infants, and 30 mothers aged under 25 years and their infants. All pregnancies had been of 38-42 weeks with normal spontaneous vaginal birth. PON and arylesterase activities were measured using paraoxon and phenylacetate substrates.
RESULTS: When the PON and arylesterase enzyme activities were compared, the PON and arylesterase activity of the mothers aged more than 35 years was found to be statistically significantly lower compared to that of the mothers aged under 25 years (P = 0.006 and P = 0.03, respectively), while there was no statistically significant difference in PON and arylesterase enzyme activity between the two groups of infants (P > 0.05).
CONCLUSION: While the PON and arylesterase enzyme activity of the mothers aged more than 35 years was found to be significantly lower compared to that of the mothers aged under 25 years, there was no statistical significance between the infants. This can be explained by the reduced PON and arylesterase enzyme activity during pregnancies at an older age, although this did not affect the PON and arylesterase enzyme activity of the infants.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22811365      PMCID: PMC6807630          DOI: 10.1002/jcla.21521

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  39 in total

1.  Basal DNA damage in individual human lymphocytes with age.

Authors:  N P Singh; D B Danner; R R Tice; J D Pearson; L J Brant; C H Morrell; E L Schneider
Journal:  Mutat Res       Date:  1991-01       Impact factor: 2.433

2.  The human serum paraoxonase/arylesterase polymorphism.

Authors:  H W Eckerson; C M Wyte; B N La Du
Journal:  Am J Hum Genet       Date:  1983-11       Impact factor: 11.025

3.  The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.

Authors:  S L Primo-Parmo; R C Sorenson; J Teiber; B N La Du
Journal:  Genomics       Date:  1996-05-01       Impact factor: 5.736

4.  Apelin levels in normal pregnancy.

Authors:  Anargyros Kourtis; Athina Gkiomisi; Maria Mouzaki; Kali Makedou; Athanasios D Anastasilakis; Konstantinos A Toulis; Spyridon Gerou; Elpida Gavana; Theodoros Agorastos
Journal:  Clin Endocrinol (Oxf)       Date:  2011-09       Impact factor: 3.478

5.  Serum paraoxonase status: a major factor in determining resistance to organophosphates.

Authors:  W F Li; L G Costa; C E Furlong
Journal:  J Toxicol Environ Health       Date:  1993 Oct-Nov

Review 6.  Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development.

Authors:  Michael Aviram; Mira Rosenblat
Journal:  Free Radic Biol Med       Date:  2004-11-01       Impact factor: 7.376

7.  The relationship between serum oestradiol levels and serum triglyceride, cholesterol and phospholipid levels in normal human pregnancy.

Authors:  R Punnonen
Journal:  Br J Obstet Gynaecol       Date:  1977-11

8.  Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action.

Authors:  Su Duy Nguyen; Dai-Eun Sok
Journal:  Free Radic Res       Date:  2003-12

9.  Paraoxonase activity and paraoxonase 1 gene polymorphism in patients with uremia.

Authors:  Stefano Biasioli; Renzo Schiavon; Luigi Petrosino; Emanuela De Fanti; Gaetano Cavalcanti; Paolo Battaglia; Antonio Fasolin
Journal:  ASAIO J       Date:  2003 May-Jun       Impact factor: 2.872

10.  Paraoxonase polymorphisms, haplotypes, and enzyme activity in Latino mothers and newborns.

Authors:  Nina Holland; Clement Furlong; Maria Bastaki; Rebecca Richter; Asa Bradman; Karen Huen; Kenneth Beckman; Brenda Eskenazi
Journal:  Environ Health Perspect       Date:  2006-07       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.